April 2011
Volume 52, Issue 14
ARVO Annual Meeting Abstract  |   April 2011
MicroRNA-184 Regulates Corneal Lymphangiogenesis
Author Affiliations & Notes
  • Sammy Grimaldo
    Optometry, University of California, Berkeley, Berkeley, California
  • Jaci Theis
    Optometry, University of California, Berkeley, Berkeley, California
  • Lu Chen
    Optometry, University of California, Berkeley, Berkeley, California
  • Footnotes
    Commercial Relationships  Sammy Grimaldo, None; Jaci Theis, None; Lu Chen, None
  • Footnotes
    Support  This work is supported in part by research grants from NIH, DoD, and University of California at Berkeley (LC).
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 6392. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sammy Grimaldo, Jaci Theis, Lu Chen; MicroRNA-184 Regulates Corneal Lymphangiogenesis. Invest. Ophthalmol. Vis. Sci. 2011;52(14):6392.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : MicroRNAs are a class of small non-coding RNAs that negatively regulate gene expression by binding to complimentary sequences of target messenger RNAs. Several microRNAs have been identified in the cornea; however, their roles are widely unknown. Here we focused on the specific role of microRNA-184 in corneal lymphangiogenesis. We also tested whether this microRNA could be used as an anti-lymphangiogenic molecule.

Methods: : The murine in vivo suture placement model was used to induce corneal inflammatory lymphangiogenesis (LG). Changes in corneal microRNA-184 expression levels were measured by RT-PCR. Additionally, microRNA-184 precursor molecules were transfected into human lymphatic endothelial cells (LEC) in vitro and their effects on LEC viability and tube formation were analyzed.

Results: : The expression of microRNA-184 was significantly decreased in inflamed and lymphatic-rich corneas. In addition, microRNA-184 transfection into LECs induces a significant suppression of cell viability and tube formation.

Conclusions: : MicroRNA-184 may function as an endogenous factor that maintains the alymphatic feature of the normal cornea. It could potentially be used as an extrinsic inhibitor of lymphatic endothelial cells. This study will shed some light on the physiological and pathological roles of microRNA-184 as well as the therapeutic implications for corneal inflammation and transplant rejection.

Keywords: neovascularization • cornea: basic science • cornea: epithelium 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.